OTCBB ALERTS

[Mandroid]

EFSF's Citroxin O2 Continues to Show Complete Eradication of Bird Flu Virus

Patricia Gruden, President/CEO of eFoodSafety.com, Inc.
(OTCBB:EFSF), announced today that the Company's Citroxin O2
ingestible formulation has shown 100% eradication of the H9N2 virus in
independent laboratory screenings. The H9N2 virus is the surrogate
organism used in laboratory testing for the Bird Flu virus.
Researchers at Prudential Equity Group, LLC have stated that they
anticipate the first signs of the Bird Flu virus spreading to the U.S.
should be within 3 weeks, with the onset of this potential pandemic
reaching California by Fall 2006 and blanketing the entire country
before year end.
"eFoodSafety.com, Inc. is acutely aware of the magnitude of this
potential pandemic and our key personnel, Robert Bowker, President of
Knock-Out Technologies, Ltd., Dr. Richard Goldfarb, President of
MedElite, Inc., Tim Matula, and myself are working around the clock
seeing to it that these products will be available should such demand
reach pandemic proportions," stated Mrs. Gruden.
As previously stated, we are awaiting results from the Citroxin O2
human clinical trials that are currently underway at Bucks County
Clinical Research (BCCR) (http://bccrinc.com/), an FDA clinical
facility, under the direction of David J. Miller, D.O., FAAP,
Executive Director of BCCR and Richard M. Goldfarb, M.D., FACS,
Medical Director of Research & Development of BCCR, a Director of
eFoodSafety.com, Inc., and President of MedElite, Inc., a wholly-owned
subsidiary of eFoodSafety.com, Inc.
"Mr. Bowker and Dr. Goldfarb have been in communication with large
multi-billion dollar pharmaceutical companies and I can assure our
shareholders we are working to pursue all available avenues for sale
of this product as the onset of this potential pandemic appears to be
imminent," added Mrs. Gruden.

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc. is dedicated to improving food and health
conditions around the world through its innovative technologies. The
company's Knock-Out Technologies, Ltd. subsidiary has developed an
environmentally safe sporicidal product formulated entirely of
food-grade components that eradicates anthrax and a germicidal
product, Big 6 Plus -- EPA Reg. No. 82723-1 that kills six major
bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus,
and Streptococcus, Avian Influenza, and Black Mold. The sporicidal
product has completed its final efficacy laboratory study requisite
for EPA registration. In the study, it eradicated both Clostridium
Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and
porous surfaces. The company's MedElite, Inc. subsidiary distributes
clinically proven products to physicians who then prescribe the
products for their patients. It is the exclusive U.S. and worldwide
distributor of the Talsyn(TM)-CI/bid Scar Cream that has been
clinically proven to facilitate and improve the appearance, redness
and strength of scars (www.talsyn.com). The company is also a
distributor for Cinnergen(TM), a non-prescription liquid whole food
nutritional supplement that promotes healthy glucose metabolism
(www.cinnergen.com), and Trimmendous(TM), a weight loss formula
focusing on the body's 24-hour metabolic processes. The company has
recently entered into a joint venture agreement with CK41 Direct, Inc.
to launch an anti-acne skin care system, with a branded name and
celebrity spokesperson to-be-announced in the near future.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly
historical are "forward-looking" statements within the meaning of
Section 27A of the Securities Act of 1933 as amended, and Section 21E
of the Securities Exchange Act of 1934, as amended. The
forward-looking statements are made based on information available as
of the date hereof, and the company assumes no obligation to update
such forward-looking statements. Editors and investors are cautioned
that such forward-looking statements invoke risk and uncertainties and
the company's actual results may differ from these forward-looking
statements. Such risks and uncertainties include but are not limited
to demand for the company's products and services, our ability to
continue to develop markets, general economic conditions, our ability
to secure additional financing for the company and other factors that
may be more fully described in reports to shareholders and periodic
filings with the Securities and Exchange Commission.



KEYWORD: NORTH AMERICA ARIZONA UNITED STATES
INDUSTRY KEYWORD: HEALTH FITNESS & NUTRITION INFECTIOUS DISEASES PHARMACEUTICAL PRODUCT/SERVICE
SOURCE: eFoodSafety.com, Inc.


CONTACT INFORMATION:
Redwood Consultants, LLC
Jens Dalsgaard, 415-884-0348